AIM logo
Alcohol in
Moderation
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • Cognitive decline
  • Parkinsons' disease& alcohol
  • Arthritis& alcohol
  • Stroke
  • Women& alcohol
    • Breast cancer
    • Pregnancy
Choose a Topic
June 2019
General health

Changes in the human metabolome associated with alcohol use

The metabolome refers to the functional status of the cell, organ or the whole body. Metabolomic methods measure the metabolome (metabolite profile) which can be used to examine disease progression and treatment responses.
A research group reviewed metabolomics studies examining effects of alcohol use in humans. A literature search was performed to identify reports on changes in the human metabolite profile associated with alcohol use. 23 relevant articles published before end of 2018 were found.
Most studies had investigated plasma, serum or urine samples; only four studies had examined other sample types (liver, faeces and broncho- alveolar lavage fluid). Levels of 51 metabolites were altered in two or more of the reviewed studies. Alcohol use was associated with changes in the levels of lipids and amino acids. In general, levels of fatty acids, phosphatidylcholine diacyls
and steroid metabolites tended to increase, whereas those of phosphatidylcholine acyl-alkyls and hydroxysphingomyelins declined. Common alterations in circulatory levels of amino acids included decreased levels of glutamine, and increased levels of tyrosine and alanine.
More studies, especially with a longitudinal study design, or using more varied sample materials (e.g. organs or saliva), are needed to clarify alcohol- induced diseases and alterations at a target organ level. The researchers state that hopefully, this will lead to the discovery of new treatments, improved recognition of individuals at high risk and identification of those subjects who would benefit most from certain treatments.
Source: Changes in the Human Metabolome Associated With Alcohol Use: A Review. Taija Voutilainen Olli Kärkkäinen. Alcohol and Alcoholism, Volume 54, Issue 3, May 2019, Pages 225–234.
doi.org/10.1093/alcalc/agz030
Drinking & You logo
Drinking & You
A global portal providing advice about responsible alcohol consumption, individual country government guidelines and your health.
Go to website
International Scientific Forum on Alcohol Research logo
International Scientific Forum on Alcohol Research
The International Scientific Forum on Alcohol Research (ISFAR) is a group of 45 specialist Professors and Medics who produce balanced and well researched analysis of emerging research papers alcohol and health.
Go to website

To receive notification of updates to the website, please subscribe here

Name(Required)

Topics

Harmful consumption

& alcohol

Healthy lifestyle

& alcohol

Genetics

& alcohol

Depression

& alcohol

Mental health

& alcohol

All-cause mortality

& alcohol

Cancer

& alcohol

Diabetes

& alcohol

Heart

& alcohol

Antioxidants

& alcohol

Bone mineral density

& alcohol

The brain

& alcohol

General health

& alcohol

Gut health

& alcohol

J-shaped curve

& alcohol

The kidneys

& alcohol

The liver

& alcohol

Mediterranean diet

& alcohol

Metabolic syndrome/weight

& alcohol

Moderate drinking

Old age

& alcohol

Parkinsons' disease

& alcohol

Arthritis

& alcohol

Stroke

& alcohol

Women

& alcohol

Latest articles

Reevaluating the alcohol–cancer link: Long-term cancer mortality outcomes in the REGARDS Study

Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol-free and low-alcohol products in higher risk groups

Alcohol consumption and molecular subtypes of colorectal cancer: pooled observational and Mendelian randomization analyses

Alcohol consumption and the incidence of hyperuricemia in Japanese men and women

Alcohol-attributable cancer risk and burden estimates for Australia’s updated alcohol consumption guidelines

Aim Digest

September 2026

June 2026

May 2026

April 2026

February 2026

© Alcohol In Moderation, 2026.
Web design by Rubber Duckers
Close menu
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
Close menu
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • ← Back
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • ← Back
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • ← Back
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • ← Back
    • Cognitive decline
  • Parkinsons' disease& alcohol
  • Arthritis& alcohol
  • Stroke
  • Women& alcohol
    • ← Back
    • Breast cancer
    • Pregnancy